Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to alixorexton for the treatment of narcolepsy type 1 (NT1), ...

The latest announcement is out from Alkermes ( (ALKS) ).

Investing.com -- Alkermes Plc (NASDAQ:ALKS) stock rose 3.4% in premarket trade Tuesday after the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to the company’s ...

This month, I’ll share some of the free software I use to understand how TV signals make it from the transmitter to the ...

Investing.com -- East Star Resources Plc (LSE:EST) has reported positive drilling results from its Verkhuba Copper Deposit in Kazakhstan, confirming deep mineralisation and shallow extensions to the ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

For inspiration on how to make the most of your second reset of the school year, we checked in with contributors to The ...

GH Research is scheduled to update on the FDA status of GH001 and outline its global Phase 3 plans for treatment-resistant ...

HHS’s move Monday to overhaul the childhood vaccine schedule without public input marks Health Secretary Robert F. Kennedy Jr ...

Bump up your salary in 2026 to as much as 56% with the help of these five AI courses taught by Stanford, MIT and others.

HMBD-501 is a HER3-targeted ADC with a differentiated mechanism of action, engineered by Hummingbird Bioscience for optimal ...